4//SEC Filing
Von Seggern Christopher 4
Accession 0001209191-21-068300
CIK 0001582313other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 4:13 PM ET
Size
4.5 KB
Accession
0001209191-21-068300
Insider Transaction Report
Form 4
Von Seggern Christopher
Chief Commercial Officer
Transactions
- Purchase
Common Shares
2021-12-06$24.40/sh+4,000$97,600→ 4,000 total
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001821192
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 4:13 PM ET
- Size
- 4.5 KB